• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Infective endocarditis by carbapenem-resistant Gram-negative bacteria - a systematic review.耐碳青霉烯革兰阴性菌所致感染性心内膜炎——一项系统评价
Germs. 2024 Jun 30;14(2):149-161. doi: 10.18683/germs.2024.1427. eCollection 2024 Jun.
2
Infective Endocarditis by Species-A Systematic Review.按物种分类的感染性心内膜炎——一项系统综述
J Clin Med. 2024 Oct 2;13(19):5887. doi: 10.3390/jcm13195887.
3
Infective Endocarditis by Species-A Narrative Review.按菌种分类的感染性心内膜炎——一篇综述
Pathogens. 2024 Jul 17;13(7):594. doi: 10.3390/pathogens13070594.
4
Infective endocarditis by species: a systematic review.种所致感染性心内膜炎:系统评价。
J Chemother. 2021 Jul;33(4):203-215. doi: 10.1080/1120009X.2020.1812804. Epub 2020 Sep 2.
5
Infective endocarditis by species: a systematic review.种所致感染性心内膜炎:系统评价。
J Chemother. 2022 Oct;34(6):347-359. doi: 10.1080/1120009X.2022.2043513. Epub 2022 Feb 24.
6
Infective endocarditis by species: a systematic review.种所致感染性心内膜炎:系统评价。
J Chemother. 2021 Oct;33(6):365-374. doi: 10.1080/1120009X.2021.1888025. Epub 2021 Feb 19.
7
Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌引起的碳青霉烯类和多黏菌素耐药菌血症的流行率和 30 天全因死亡率:长达十年趋势的描述。
Int J Infect Dis. 2019 Aug;85:10-15. doi: 10.1016/j.ijid.2019.05.004. Epub 2019 May 14.
8
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.头孢地尔罗或最佳现有治疗方案治疗碳青霉烯类耐药革兰氏阴性菌引起的严重感染的疗效和安全性(CREDIBLE-CR):一项随机、开放标签、多中心、以病原体为重点、描述性的 3 期临床试验。
Lancet Infect Dis. 2021 Feb;21(2):226-240. doi: 10.1016/S1473-3099(20)30796-9. Epub 2020 Oct 12.
9
[Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].抗菌药物管理计划对多重耐药革兰阴性菌抗菌药物使用及检出率的影响
Zhonghua Er Ke Za Zhi. 2019 Jul 2;57(7):553-558. doi: 10.3760/cma.j.issn.0578-1310.2019.07.012.
10
Epidemiology and mortality outcome of carbapenem- and colistin-resistant , and bloodstream infections.碳青霉烯类和黏菌素耐药菌以及血流感染的流行病学和死亡率结果
IJID Reg. 2023 Jan 8;7:1-5. doi: 10.1016/j.ijregi.2023.01.002. eCollection 2023 Jun.

本文引用的文献

1
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.多黏菌素单药治疗与联合治疗耐碳青霉烯类微生物的比较
NEJM Evid. 2023 Jan;2(1). doi: 10.1056/evidoa2200131. Epub 2022 Dec 6.
2
Non-HACEK gram-negative bacilli endocarditis: a multicentre retrospective case-control study.非 HACEK 革兰氏阴性杆菌心内膜炎:一项多中心回顾性病例对照研究。
Infect Dis (Lond). 2023 Sep;55(9):599-606. doi: 10.1080/23744235.2023.2226212. Epub 2023 Jun 24.
3
Whipple's disease-associated infective endocarditis: a systematic review.惠尔普病相关性感染性心内膜炎:系统评价。
Infect Dis (Lond). 2023 Jul;55(7):447-457. doi: 10.1080/23744235.2023.2214610. Epub 2023 May 17.
4
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.2023 年杜克-国际心血管感染性疾病学会感染性心内膜炎标准:修改后的杜克标准更新。
Clin Infect Dis. 2023 Aug 22;77(4):518-526. doi: 10.1093/cid/ciad271.
5
A contemporary case series of Pseudomonas aeruginosa infective endocarditis.当代铜绿假单胞菌感染性心内膜炎的病例系列。
Medicine (Baltimore). 2023 Mar 31;102(13):e32662. doi: 10.1097/MD.0000000000032662.
6
Successful ceftazidime-avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis.头孢他啶-阿维巴坦成功治疗耐多药铜绿假单胞菌感染性心内膜炎患者
Infection. 2022 Aug;50(4):1039-1041. doi: 10.1007/s15010-022-01834-7. Epub 2022 Apr 17.
7
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.全球碳青霉烯类耐药革兰氏阴性菌的威胁
Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022.
8
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
9
Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome.抗菌药物耐药性:流行情况、经济负担、耐药机制和克服策略。
Eur J Pharm Sci. 2022 Mar 1;170:106103. doi: 10.1016/j.ejps.2021.106103. Epub 2021 Dec 20.
10
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).欧洲临床微生物学和传染病学会(ESCMID)治疗多重耐药革兰氏阴性杆菌感染的指南(由欧洲重症监护医学学会认可)。
Clin Microbiol Infect. 2022 Apr;28(4):521-547. doi: 10.1016/j.cmi.2021.11.025. Epub 2021 Dec 16.

耐碳青霉烯革兰阴性菌所致感染性心内膜炎——一项系统评价

Infective endocarditis by carbapenem-resistant Gram-negative bacteria - a systematic review.

作者信息

Pitsikakis Konstantinos, Skandalakis Michail, Fragkiadakis Konstantinos, Baliou Stella, Ioannou Petros

机构信息

School of Medicine, University of Crete, 71003 Heraklion, Greece.

MD, MSc, School of Medicine, University of Crete, 71003 Heraklion, Greece.

出版信息

Germs. 2024 Jun 30;14(2):149-161. doi: 10.18683/germs.2024.1427. eCollection 2024 Jun.

DOI:10.18683/germs.2024.1427
PMID:39493737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11527486/
Abstract

INTRODUCTION

Infective endocarditis (IE) is a disease that may frequently lead to significant morbidity and is associated with high mortality rates. Even though IE is classically caused by Gram-positive bacteria, Gram-negative bacteria may seldom cause IE. Antimicrobial resistance (AMR) may pose significant problems in treating IE, especially for carbapenem-resistant pathogens. This study aimed to review all cases of IE by carbapenem-resistant Gram-negative bacteria in a systematic way and present information on epidemiology, clinical findings, treatment, and outcomes.

METHODS

A systematic review of PubMed, Cochrane Library, and Scopus (all published studies up to 6 August 2023) for published studies providing information on epidemiology, clinical findings, treatment, and outcomes of IE by carbapenem-resistant Gram-negative bacteria was performed.

RESULTS

A total of 24 studies containing data from 26 patients were included. Among all patients, 53.9% were male, and the median age was 66 years. Among all patients, 38.5% had a history of a prosthetic valve. The most commonly affected valve was the aortic, followed by the mitral valve. Fever, sepsis, emboli, and shock were the most frequent clinical findings. The most commonly isolated pathogens were and . Aminoglycosides, colistin, cephalosporins, and carbapenems were the most commonly used antimicrobials. Surgery was performed in 53.8% of patients. Mortality was 38.5%.

CONCLUSIONS

The development of infection control measures and antimicrobial stewardship interventions is needed to reduce the spread of AMR and the likelihood of this fatal infection.

摘要

引言

感染性心内膜炎(IE)是一种常导致严重发病且死亡率高的疾病。尽管IE通常由革兰氏阳性菌引起,但革兰氏阴性菌很少引发IE。抗菌药物耐药性(AMR)在治疗IE时可能带来重大问题,尤其是对于耐碳青霉烯类病原体。本研究旨在系统回顾所有耐碳青霉烯类革兰氏阴性菌引起的IE病例,并呈现有关流行病学、临床发现、治疗及预后的信息。

方法

对PubMed、Cochrane图书馆和Scopus(截至2023年8月6日的所有已发表研究)进行系统综述,以获取有关耐碳青霉烯类革兰氏阴性菌引起的IE的流行病学、临床发现、治疗及预后的已发表研究信息。

结果

共纳入24项包含26例患者数据的研究。所有患者中,53.9%为男性,中位年龄为66岁。所有患者中,38.5%有人工瓣膜病史。最常受累的瓣膜是主动脉瓣,其次是二尖瓣。发热、败血症、栓塞和休克是最常见的临床发现。最常分离出的病原体是[此处原文缺失具体病原体名称]和[此处原文缺失具体病原体名称]。氨基糖苷类、黏菌素、头孢菌素和碳青霉烯类是最常用的抗菌药物。53.8%的患者接受了手术。死亡率为38.5%。

结论

需要制定感染控制措施和抗菌药物管理干预措施,以减少AMR的传播及这种致命感染发生的可能性。